Stirling Products Limited
HOME
CONTACT
Stirling Products - Animal Health Biotechnology Stirling Products - Investment opportunity
Pharmaceutical Metabolic Modifiers
 
Stirling Products Welcome to Stirling Products
     

     

Welcome to Stirling Products

Stirling Products Limited (Stirling) is an animal healthcare company focused on the development and commercialisation of metabolic modifiers for a range of indications in international animal healthcare markets. Stirling is a public Australian company (ASX:STI) headquartered in Perth, Australia.

In August 2007 Stirling Products acquired Progressive BioActives Inc, a Canadian company that has developed an extremely purified form of yeast beta glucan for the livestock industry. This product is known in the market as ProValeTM. Beta glucan is a natural immunopotentiator. In other words, when livestock species consume the beta glucan, their immunity is enhanced thus reducing the need for antibiotic use as growth agents. This has great applications in poultry, swine and aquaculture.

Stirling also has a pharmaceutical compound under development - R-salbutamol (also known as R-albuterol). R-salbutamol is a highly purified version of salbutamol, a well-established drug that has been used in the treatment of human asthma for more than 25 years.

Stirling's three technology platforms for R-salbutamol are:

1. Growth agents in livestock

2. Treatment for obesity in companion animals (dogs and cats)

3. Treatment of respiratory disorders in horses (primarily heaves)

With the addition of Stirling Products North America (trading as Progressive BioActives), Stirling has the ability to generate revenue in the immediate future from sales of ProValeTM, as well as possessing a unique complimentary product for the R-salbutamol technology.

I invite you to review the information contained in the pages of this website. The navigation bars have been incorporated to direct you to particular areas of interest. Should you have any comments or questions about the structure or content of this website, please feel free to contact the company on info@stirlingproducts.net.

In the interests of continuous improvement, we are committed to providing a friendly website for potential investors and those interested in the company. As a result, the website will be up-dated from time to time with new information concerning the company's activities as it becomes available.

We thank you for your interest in Stirling.

Dr Calvin London
Managing Director
Stirling Products Limited

     



 
This site was created by Elk Software Group